Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides
The DOI matches its Crossref record; 18 of the 19 references it cites were found in a registry or an index.
Abstract
From a plaque biopsy of a patient with mycosis fungoides, two different continuous cell lines were established by including both IL-2 and IL-4 in the culture medium. Both continuous cell lines appeared with characteristic chromosome markers after approximately 40 cell population doublings. The initial karyotype recognized in T cells from the skin biopsy was 46,XY and the karyotypes of the continuous cell strains were 46,XY, -18, + i(18q) and another with multiple chromosome aberrations as described in Sezary T-cell leukemia. Phenotyping with monoclonal antibodies and T-cell receptor analysis indicates that the latter cell strain represents a minority of T-cells in the plaque. Due to its many chromosomal aberrations it probably represents the malignant cell, which may be a central cell in the immune stimulation taking place in the skin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Here, we extend the utility of CITE-seq and the related Cell Hashing method for multiplexing and doublet detection21 to 5’ capture-based scRNA-seq methods, exemplified by the 10× Genomics 5P / V(D)J system, allowing the detection of surface proteins together with the scRNA-seq and clonotype features currently offered by the 10× Genomics system22,23.”
From Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells (2019) · cites this paper as [23]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“Total RNA was isolated from approximately 1 X l0 T cells by acid guanidinium thiocyanate-phenol-chloroform extraction ( 4 ) and used for the synthesis of first strand cDNA using oligo (dT) as primer and reverse transcriptase (Superscript, BRL, Gaithersburg, MD) according to the suppliers instructions, cDNA from the ce…”
MethodInteraction of Staphylococcus aureus toxin "superantigens" with human T cells.
Choi, Y. W., Kotzin, B., Herron, L., Callahan, J., Marrack, P., & Kappler, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8941 · Cited by 955
Weiss, L. M., Hu, E., Wood, G. S., Moulds, C., Cleary, M. L., Warnke, R., & Sklar, J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508293130903 · Cited by 339 · cited 1×
“During the past decade, markers have been sought that might be specific for these disorders, including morphology of the Sezary cell nucleus (12), antigens on leukemic cells (2), and lately T-cell receptor gene-rearrangement studies ( 18 ).”
BackgroundCutaneous T cell lymphoma: Mycosis fungoides, Sézary syndrome, and other variants
Edelson, R. L. (1980) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(80)80385-9 · Cited by 335
Ultrastructure of abnormal cells in Sezary syndrome, mycosis fungoides, and parapsoriasis en plaque
Lutzner, M. A. (1971) · Archives of Dermatology · doi:10.1001/archderm.103.4.375 · Cited by 195
Van Scott, E. J., & Kalmanson, J. D. (1973) · Cancer · doi:10.1002/1097-0142(197307)32:1<18::aid-cncr2820320103>3.0.co;2-q · Cited by 179
Nonspecificity of Characteristic Cells in Mycosis Fungoides
Flaxman, B. A. (1971) · Archives of Dermatology · doi:10.1001/archderm.1971.04000200029006 · Cited by 149
Ultrastructure of Abnormal Cells
Lutzner, M. A. (1971) · Archives of Dermatology · doi:10.1001/archderm.1971.04000160025005 · Cited by 142 · cited 1×
“During the past decade, markers have been sought that might be specific for these disorders, including morphology of the Sezary cell nucleus ( 12 ), antigens on leukemic cells (2), and lately T-cell receptor gene-rearrangement studies (18).”
BackgroundA continuous T-cell line from a patient with S�zary syndrome
Kaltoft, K., Bisballe, S., Rasmussen, H. F., Thestrup‐Pedersen, K., Thomsen, K., & Sterry, W. (1987) · Archives of Dermatological Research · doi:10.1007/bf00431220 · Cited by 122 · cited 7×
“In both SS and MF these clones are the malignant ceils (3,6, 9 ).”
BackgroundMethodInfluentialSelf-citationINITIAL EVENT IN MYCOSIS FUNGOIDES OF THE SKIN IS VIRAL INFECTION OF EPIDERMAL LANGERHANS CELLS
MacKie, R. M. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90529-8 · Cited by 84 · cited 1×
“MF and SS ( 13 ), and we believe that the hallmark for MF and SS is a malignant chromosomal, very aberrant clone like the My-La marker chromosome described here, and a similar chromosomal aberrant clone described by us in a continuous cell line from SS (9).”
Background
Research works printed but not linked: 1
- Knapp, W.; Rieber, P.; Dorken, B. et al., editors. Leucocyte typing IV. England: Oxford University Press; 1990.
Cited by
Mimitou, E. P., Cheng, A., Montalbano, A., Hao, S., Stoeckius, M., Legut, M., Roush, T., Herrera, A., Papalexi, E., Ouyang, Z., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0392-0 · Cited by 520
van Doorn, R., Zoutman, W. H., Dijkman, R., de Menezes, R. X., Commandeur, S., Mulder, A. A., van der Velden, P. A., Vermeer, M. H., Willemze, R., Yan, P. S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.353 · Cited by 228
Nielsen, M., Kaltoft, K., Nordahl, M., Röpke, C., Geisler, C., Mustelin, T., Dobson, P., Svejgaard, A., & Ødum, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6764 · Cited by 220
Self-citationConstitutive STAT3 Activation in Intestinal T Cells from Patients with Crohn's Disease
Lovato, P., Brender, C., Agnholt, J., Kelsen, J., Kaltoft, K., Svejgaard, A., Eriksen, K. W., Woetmann, A., & Ødum, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207999200 · Cited by 199
Self-citationHeinzerling, L., Künzi, V., Oberholzer, P. A., Kündig, T., Naim, H., & Dummer, R. (2005) · Blood · doi:10.1182/blood-2004-11-4558 · Cited by 188
Sommer, V. H., Clemmensen, O. J., Nielsen, O., Wasik, M., Lovato, P., Brender, C., Eriksen, K. W., Woetmann, A., Kaestel, C. G., Nissen, M. H., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403385 · Cited by 162
Eriksen, K., Kaltoft, K., Mikkelsen, G., Nielsen, M., Zhang, Q., Geisler, C., Nissen, M., Röpke, C., Wasik, M., & Ødum, N. (2001) · Leukemia · doi:10.1038/sj.leu.2402093 · Cited by 162
Self-citationFOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival
Gjerdrum, L. M., Woetmann, A., Odum, N., Burton, C. M., Rossen, K., Skovgaard, G. L., Ryder, L. P., & Ralfkiaer, E. (2007) · Leukemia · doi:10.1038/sj.leu.2404913 · Cited by 158
Serological detection of cutaneous T-cell lymphoma-associated antigens
Eichmüller, S. B., Usener, D., Dummer, R., Stein, A., Thiel, D., & Schadendorf, D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.629 · Cited by 150
Woetmann, A., Nielsen, M., Christensen, S. T., Brockdorff, J., Kaltoft, K., Engel, A.-M., Skov, S., Brender, C., Geisler, C., Svejgaard, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10620 · Cited by 131
Self-citationMast cells play a protumorigenic role in primary cutaneous lymphoma
Rabenhorst, A., Schlaak, M. S., Heukamp, L. C., Förster, A., Theurich, S., von Bergwelt‐Baildon, M., Büttner, R., Kurschat, P., Mauch, C., Roers, A., et al. (2012) · Blood · doi:10.1182/blood-2012-03-415638 · Cited by 130
STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma
Brender, C., Nielsen, M., Kaltoft, K., Mikkelsen, G., Zhang, Q., Wasik, M., Billestrup, N., & Ødum, N. (2001) · Blood · doi:10.1182/blood.v97.4.1056 · Cited by 129
Self-citationTargetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
Ng, S. Y., Yoshida, N., Christie, A. L., Ghandi, M., Dharia, N. V., Dempster, J., Murakami, M., Shigemori, K., Morrow, S. N., Van Scoyk, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04356-9 · Cited by 113
Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma
Krejsgaard, T., Vetter‐Kauczok, C. S., Woetmann, A., Lovato, P., Labuda, T., Eriksen, K., Zhang, Q., Becker, J. C., & Ødum, N. (2006) · Leukemia · doi:10.1038/sj.leu.2404350 · Cited by 116
Wozniak, M. B., Villuendas, R., Bischoff, J. R., Aparicio, C. B., Martínez-Leal, J. F., de la Cueva, P., Rodríguez, M. E., Herreros, B., Martín-Pérez, D., Longo, M. I., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.013870 · Cited by 114
Human retinal pigment epithelial cell-induced apoptosis in activated T cells.
Jørgensen, A. K., Wiencke, A. K., la Cour, M., Kæstel, C. G., Madsen, H. O., Hamann, S., Lui, G. M., Scherfig, E., Prause, J. U., Svejgaard, A., et al. (1998) · PubMed · Cited by 106
Fanok, M. H., Sun, A. L., Fogli, L. K., Narendran, V., Eckstein, M., Kannan, K. S., Dolgalev, I., Lazaris, C., Heguy, A., Laird, M. E., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.10.028 · Cited by 101
“1991) and the MyLa 2059 line is derived from a plaque biopsy of an MF patient (Kaltoft et al. 1992).”
BackgroundLee, C. S., Ungewickell, A., Bhaduri, A., Qu, K., Webster, D. E., Armstrong, R. J., Weng, W., Aros, C. J., Mah, A., Chen, R., et al. (2012) · Blood · doi:10.1182/blood-2012-04-423061 · Cited by 93
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome
Krejsgaard, T., Gjerdrum, L. M. R., Ralfkiaer, E. M., Lauenborg, B. T., Eriksen, K., Mathiesen, A.-M., Bovin, L. F., Gniadecki, R., Geisler, C., Ryder, L. P., et al. (2008) · Leukemia · doi:10.1038/leu.2008.224 · Cited by 89
Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins
Woetmann, A., Lovato, P., Eriksen, K. W., Krejsgaard, T., Labuda, T., Zhang, Q., Mathiesen, A., Geisler, C., Svejgaard, A., Wasik, M. A., et al. (2006) · Blood · doi:10.1182/blood-2006-04-017863 · Cited by 86
Increased Sensitivity to Interferon-α in Psoriatic T Cells
Eriksen, K. W., Lovato, P., Skov, L., Krejsgaard, T., Kaltoft, K., Geisler, C., & Ødum, N. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23864.x · Cited by 85
“The human CD8þ /CD4 / IFNARþ /CD25þ Tcell lines, Control-1, -2, and -3, are continuous T cell lines derived from uninfected skin of three different patients with diseases other than psoriasis as described in detail elsewhere (Kaltoft et al, 1992, 1994).”
BackgroundSelf-citationNotch1 as a potential therapeutic target in cutaneous T-cell lymphoma
Kamstrup, M. R., Gjerdrum, L. M. R., Biskup, E., Lauenborg, B. T., Ralfkiaer, E. M., Woetmann, A., Ødum, N., & Gniadecki, R. (2010) · Blood · doi:10.1182/blood-2009-12-260216 · Cited by 85
Promoter Methylation Regulates SAMHD1 Gene Expression in Human CD4+ T Cells
de Silva, S., Hoy, H., Hake, T. S., Wong, H. K., Porcu, P., & Wu, L. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.447201 · Cited by 91
“The cutaneous T cell lymphoma cell lineMyLa (20) was a gift from Michael Girardi (Yale University).”
BackgroundKarenko, L., Hyytinen, E., Sarna, S. J., & Ranki, A. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12285617 · Cited by 85
Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNα
Brender, C., Lovato, P., Sommer, V. H., Woetmann, A., Mathiesen, A.-M., Geisler, C., Wasik, M. A., & Ødum, N. (2004) · Leukemia · doi:10.1038/sj.leu.2403610 · Cited by 84
“Materials and methods Cell lines Cell lines established from CTCL patients have previously been described”
MethodLitvinov, I. V., Cordeiro, B., Fredholm, S., Ødum, N., Zargham, H., Huang, Y., Zhou, Y., Pehr, K., Kupper, T. S., Woetmann, A., et al. (2014) · Cell Cycle · doi:10.4161/15384101.2014.947759 · Cited by 83
“MyLa is a commonly used cell line derived from an MF patient skin biopsy.(41) As summarized in Table S2, out of 11 cell lines, this line is the only one derived from a skin biopsy of a typical MF patient.”
MethodDuval, L., Schmidt, H., Kaltoft, K., Fode, K., Jensen, J. J., Soerensen, S. M., Nishimura, M. I., & von der Maase, H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1485 · Cited by 83
Self-citationNielsen, M., Nissen, M. H., Gerwien, J. G., Zocca, M.-B., Rasmussen, H. M., Nakajima, K., Röpke, C., Geisler, C., Kaltoft, K., & Ødum, N. (2002) · Blood · doi:10.1182/blood.v99.3.973 · Cited by 69
Self-citationEctopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma
Krejsgaard, T., Vetter‐Kauczok, C. S., Woetmann, A., Kneitz, H., Eriksen, K. W., Lovato, P., Zhang, Q., Wasik, M. A., Geisler, C., Ralfkiaer, E. M., et al. (2009) · Blood · doi:10.1182/blood-2008-09-181024 · Cited by 64
Rozati, S., Cheng, P. F., Widmer, D. S., Fujii, K., Levesque, M. P., & Dummer, R. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1435 · Cited by 65
“Materials and Methods Cell lines MyLa, SeAx, and Hut78, well-established CTCL cell lines (17, 18), were cultured in RPMI1640 medium (Invitrogen) supplemented with 10% heat-inactivated FBS, glutamine (2 mmol/L), and streptomycin (100 mg/mL) at 37 C, 5% CO2, and 95% humidity.”
MethodNetchiporouk, E., Gantchev, J. K., Tsang, M., Thibault, P., Watters, A. K., Hughes, J.-D. M., Ghazawi, F. M., Woetmann, A., Ødum, N., Sasseville, D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21619 · Cited by 69
“com/oncotarget (Copenhagen, Denmark) and were initially described elsewhere [31, 58-61].”
cTAGE: A Cutaneous T Cell Lymphoma Associated Antigen Family with Tumor-Specific Splicing
Koch, J., Dübel, S., Usener, D., Schadendorf, D., & Eichmüller, S. B. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12318.x · Cited by 61
Testing the Role of gp96 as Peptide Chaperone in Antigen Processing
Demine, R., & Walden, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501233200 · Cited by 61
Cyrenne, B. M., Lewis, J. M., Weed, J. G., Carlson, K. R., Mirza, F. N., Foss, F. M., & Girardi, M. (2017) · Blood · doi:10.1182/blood-2017-06-792150 · Cited by 64
Karenko, L., Sarna, S. J., Kähkönen, M., & Ranki, A. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05116.x · Cited by 60
Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome
Braun, F., Grabarczyk, P., Möbs, M., Braun, F., Eberle, J., Beyer, M., Sterry, W., Busse, F., Schröder, J., Delin, M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.101 · Cited by 58
Cytogenetic Findings in Cell Lines from Cutaneous T-Cell Lymphoma
Kaltoft, K., Hansen, B. H., & Thestrup‐Pedersen, K. (1994) · Dermatologic Clinics · doi:10.1016/s0733-8635(18)30176-1 · Cited by 57
Self-citationAl‐Yacoub, N., Fecker, L. F., Möbs, M., Plötz, M., Braun, F., Sterry, W., & Eberle, J. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.125 · Cited by 61
Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma
Prutsch, N., Gurnhofer, E., Suske, T., Liang, H.-C., Schlederer, M., Roos, S., Wu, L. C., Simonitsch‐Klupp, I., Alvarez-Hernandez, A., Kornauth, C., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0239-1 · Cited by 51
Kim, S. R., Lewis, J. M., Cyrenne, B. M., Monico, P. F., Mirza, F. N., Carlson, K. R., Foss, F. M., & Girardi, M. (2018) · Oncotarget · doi:10.18632/oncotarget.25670 · Cited by 56
Braun, F., Fecker, L. F., Schwarz, C., Walden, P., Assaf, C., Dürkop, H., Sterry, W., & Eberle, J. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700868 · Cited by 52
“Cell culture and quantification of apoptosis Four CTCL cell lines have been used: MyLa derived from a plaque biopsy of a patient with MF (Kaltoft et al., 1992); SeAx (Kaltoft et al.”
MethodSTAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides
Vieyra-Garcia, P. A., Wei, T., Naym, D. G., Fredholm, S., Fink‐Puches, R., Cerroni, L., Ødum, N., O’Malley, J. T., Gniadecki, R., & Wolf, P. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1784 · Cited by 52
“Cell lines MyLa2000 and PB2B cells, derived from MF patients (21) and Hut78 derived from the blood of a patient with S ezary syndrome (22) were used for cell culture investigations.”
MethodMélard, P., Idrissi, Y., Andrique, L., Poglio, S., Prochazkova-Carlotti, M., Berhouet, S., Boucher, C., Laharanne, E., Chevret, E., Pham-Ledard, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11930 · Cited by 48
“Another case (#9, Supplementary Table S1) harbored a c.22-4C>A somatic intronic mutation, 4 basepairs upstream of exon 2, predicted to lead to exon 2 skipping, with deleterious frameshift effect (Figure 4A).”
BackgroundMethodInfluentialA novel xenograft model of cutaneous T‐cell lymphoma
Krejsgaard, T., Kopp, K., Ralfkiaer, E. M., Willumsgaard, A. E., Eriksen, K. W., Labuda, T., Rasmussen, S. B., Mathiesen, A., Geisler, C., Lauenborg, B. T., et al. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01138.x · Cited by 50
Hamrouni, A., Fogh, H., Zak, Z., Ødum, N., & Gniadecki, R. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4099 · Cited by 47
“The sensitivity of our method for detection of TCR clonality was at the level of 1%, as demonstrated by a spike-in experiment where different numbers of MyLa cells (T-cell lymphoma line (24)) were mixed with PBMCs from a healthy donor.”
MethodEctopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
Litvinov, I. V., Cordeiro, B., Huang, Y., Zargham, H., Pehr, K., Doré, M.-A., Gilbert, M. J., Zhou, Y., Kupper, T. S., & Sasseville, D. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0307 · Cited by 46
β 1 integrin activation on human neutrophils promotes β 2 integrin-mediated adhesion to fibronectin
van den Berg, J. M., Mul, E. P. J., Schippers, E., Weening, J. J., Roos, D., & Kuijpers, T. W. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200101)31:1<276::aid-immu276>3.0.co;2-d · Cited by 68
Self-citationMcGrath, J. A., Ishida-Yamamoto, A., Shimizu, H., Fine, J., & Eady, R. A. (1994) · Acta Dermato Venereologica · doi:10.2340/0001555574201205 · Cited by 45
Fellenberg, F., Hartmann, T. B., Dummer, R., Usener, D., Schadendorf, D., & Eichmüller, S. B. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22613.x · Cited by 45
Tumor‐specific antigens in cutaneous T‐cell lymphoma: Expression and sero‐reactivity
Eichmüller, S. B., Usener, D., Thiel, D., & Schadendorf, D. (2003) · International Journal of Cancer · doi:10.1002/ijc.10967 · Cited by 43
COX-2-dependent PGE2 acts as a growth factor in mycosis fungoides (MF)
Kopp, K., Kauczok, C. S., Lauenborg, B. T., Krejsgaard, T., Eriksen, K., Zhang, Q., Wasik, M. A., Geisler, C., Ralfkiaer, E. M., Becker, J. C., et al. (2010) · Leukemia · doi:10.1038/leu.2010.66 · Cited by 43
Braun, F., Al‐Yacoub, N., Plötz, M., Möbs, M., Sterry, W., & Eberle, J. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.316 · Cited by 44
Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma
Litvinov, I. V., Netchiporouk, E., Cordeiro, B., Zargham, H., Pehr, K., Gilbert, M. J., Zhou, Y., Moreau, L., Woetmann, A., Ødum, N., et al. (2014) · OncoImmunology · doi:10.4161/21624011.2014.970025 · Cited by 46
Linnemann, T., Gellrich, S., Lukowsky, A., Mielke, A., Audring, H., Sterry, W., & Walden, P. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.05970.x · Cited by 43
Blümel, E. P., Willerslev-Olsen, A., Gluud, M., Lindahl, L. M., Fredholm, S., Nastasi, C., Krejsgaard, T., Surewaard, B. G. J., Koralov, S. B., Hu, T., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1641387 · Cited by 39
Chung, J., Shiue, L. H., Duvic, M. A., Pandya, A. G., Cruz, P. D., & Ariizumi, K. (2011) · Blood · doi:10.1182/blood-2010-08-302034 · Cited by 39
Mazuz, M., Tiroler, A., Moyal, L., Hodak, E., Nadarajan, S., Vinayaka, A. C., Gorovitz, B., Lubin, I., Drori, A., Drori, G., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27528 · Cited by 36
“My-La CD4+ cell line (95051032, ECACC) was established from skin biopsy of 82-year-old Caucasian male with 80% Body Surface Area (BSA) involvement by MF with extensive lymphadenopathy (stage IIA) [40].”
BackgroundSEREX identification of new tumour-associated antigens in cutaneous T-cell lymphoma
Hartmann, T. B., Thiel, D., Dummer, R., Schadendorf, D., & Eichmüller, S. B. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.05651.x · Cited by 35
Lauenborg, B. T., Christensen, L. D., Ralfkiær, U., Kopp, K., Jønson, L., Dabelsteen, S., Bonefeld, C. M., Geisler, C., Gjerdrum, L. M. R., Zhang, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3837 · Cited by 34
“The malignant T cell line MyLa2059 and PB2B and the non-malignant T cell lines MyLa1850 and MySi were generated from patients with MF [40-42].”
BackgroundImmunoregulatory events in the skin of patients with cutaneous T-cell lymphoma.
Hansen, E. R. (1996) · PubMed · Cited by 33
IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity
Hansen, M. L., Woetmann, A., Krejsgaard, T., Kopp, K., Søkilde, R., Litman, T., Straten, P. T., Geisler, C., Wasik, M. A., Ødum, N., et al. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.07.008 · Cited by 31
Molecular cytogenetics in the study of cutaneous T-cell lymphomas (CTCL)
Karenko, L., Hahtola, S., & Ranki, A. (2007) · Cytogenetic and Genome Research · doi:10.1159/000108320 · Cited by 35
“To propagate the growth of CTCL cells in vitro, various cytokines have been used (Kaltoft et al., 1992; Bagot et al., 1998), and new methods for extracting Tcells (Clark et al.”
BackgroundMethodEstablishment of a mouse xenograft model for mycosis fungoides
Thaler, S., Burger, A. M., Schulz, T. F., Brill, B., Bittner, A., Oberholzer, P. A., Dummer, R., & Schnierle, B. S. (2004) · Experimental Dermatology · doi:10.1111/j.0906-6705.2004.00201.x · Cited by 31
Common clonal chromosome aberrations in cytokine-dependent continuous human T-lymphocyte cell lines
Kaltoft, K., Hansen, B. H., Pedersen, C. B., Pedersen, S. L., & Thestrup‐Pedersen, K. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(95)00118-2 · Cited by 31
Self-citationVersican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy
Fujii, K., Karpova, M. B., Asagoe, K., Georgiev, O., Dummer, R., & Urosevic‐Maiwald, M. (2015) · Leukemia · doi:10.1038/leu.2015.103 · Cited by 28
Recombinant Measles Virus Induces Cytolysis of Cutaneous T-Cell Lymphoma In Vitro and In Vivo
Künzi, V., Oberholzer, P. A., Heinzerling, L., Dummer, R., & Naim, H. Y. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700529 · Cited by 30
“Kaltoft, Aahus, Denmark), and HUT78 (4 passages) (Kaltoft et al., 1987; Kaltoft et al., 1992), were incubated in Rosewell Park Memorial Institute medium 1640 (GIBCO BRL, Scotland, UK, Catalog No.”
MethodAntitumour effects in mycosis fungoides of the immunomodulatory, tellurium-based compound, AS101
Frei, G., Kremer, M., Hanschmann, K. ‐., Krause, S., Albeck, M., Sredni, B., & Schnierle, B. S. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08414.x · Cited by 30
Identification of selectively expressed genes and antigens in CTCL
Hartmann, T. B., Mattern, E., Wiedemann, N., van Doorn, R., Willemze, R., Niikura, T., Hildenbrand, R., Schadendorf, D., & Eichmüller, S. B. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00637.x · Cited by 28
Kaltoft, K., Pedersen, C. B., Hansen, B., Lemonidis, A. S., Frydenberg, J., & Thestrup‐Pedersen, K. (1994) · Archives of Dermatological Research · doi:10.1007/bf00370717 · Cited by 28
Self-citationKæstel, C. G., Jørgensen, A., Nielsen, M., Eriksen, K. W., Ødum, N., Nissen, M. H., & Röpke, C. (2002) · Experimental Eye Research · doi:10.1006/exer.2002.1183 · Cited by 27
JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL)
Vadivel, C. K., Gluud, M., Torres‐Rusillo, S., Boding, L., Willerslev-Olsen, A., Buus, T. B., Nielsen, T. K., Persson, J. L., Bonefeld, C. M., Geisler, C., et al. (2021) · Cancers · doi:10.3390/cancers13020280 · Cited by 27
Bi-phasic Effect of Interferon (IFN)-α
Eriksen, K. W., Sommer, V. H., Woetmann, A., Rasmussen, A. B., Brender, C., Svejgaard, A., Skov, S., Geisler, C., & Ødum, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310472200 · Cited by 27
Gill, R. P. K., Gantchev, J. K., Villarreal, A. M., Ramchatesingh, B. L., Netchiporouk, E., Akilov, O. E., Ødum, N., Gniadecki, R., Koralov, S. B., & Litvinov, I. V. (2022) · Cells · doi:10.3390/cells11040593 · Cited by 21
“CD4+ and CD8+ forms RPMI-1640 FBSPen/strep Advanced MF [27]”
BackgroundKaragianni, F., Piperi, C., Casar, B., de la Fuente‐Vivas, D., García‐Gómez, R., Lampadaki, K., Pappa, V., & Papadavid, E. (2022) · Cancers · doi:10.3390/cancers14041070 · Cited by 20
Chou, C., Hsieh, Y., Grubbs, C. J., Atigadda, V. R., Mobley, J. A., Dummer, R., Muccio, D. D., Eto, I., Elmets, C. A., Garvey, W. T., et al. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.03.006 · Cited by 21
Cytokine-Driven Immortalization of in vitro Activated Human T Lymphocytes
Kaltoft, K. (1998) · Experimental and Clinical Immunogenetics · doi:10.1159/000019058 · Cited by 21
Self-citationGenotraumatic T cells and cutaneous T-cell lymphoma. A causal relationship?
Thestrup‐Pedersen, K., & Kaltoft, K. (1994) · Archives of Dermatological Research · doi:10.1007/bf00370726 · Cited by 21
Self-citationOhmatsu, H., Humme, D., Gulati, N., Gonzalez, J., Möbs, M., Suárez‐Fariñas, M., Cardinale, I. R., Mitsui, H., Guttman‐Yassky, E., Sterry, W., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0199-t · Cited by 22
Soltan, M. Y., Sumarni, U., Assaf, C., Langer, P., Reidel, U., & Eberle, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051158 · Cited by 19
“It derived from a plaque biopsy of a patient with MF [40]; HuT-78 was kindly supplied by Prof.”
MethodMurga‐Zamalloa, C., Polk, A., Hanel, W. G., Chowdhury, P., Brown, N. A., Hristov, A. C., Bailey, N. G., Wang, T., Phillips, T. J., Devata, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22967 · Cited by 19
Reliable blood cancer cells' telomere length evaluation by qPCR
Ropio, J., Chebly, A., Ferrer, J., Prochazkova‐Carlotti, M., Idrissi, Y., Martin, L. A., Cappellen, D., Pham‐Ledard, A., Soares, P., Merlio, J., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.2816 · Cited by 20
Biskup, E., Naym, D. G., & Gniadecki, R. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.09.010 · Cited by 18
“The following cell lines were used in this study: MyLa2000 (derived from a plaque biopsy specimen from a patient with MF; [16]), SeAx (derived from peripheral blood of patients with Sezary syndrome; [17]), Mac2a (derived from patients with primary cutaneous CD30+ lymphoproliferative diseases; [18]).”
MethodInactivation of RUNX3/p46 Promotes Cutaneous T-Cell Lymphoma
Haider, A., Steininger, A., Ullmann, R., Hummel, M., Dimitrova, L., Beyer, M., Vandersee, S., Lenze, D., Sterry, W., Assaf, C., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.05.126 · Cited by 19
“Knowing that MyLa is derived from a patient with mycosis fungoides (Kaltoft et al., 1992), we chose it as a cell line model because it originates from mature T cells, its distal RUNX3 promoter is hypermethylated, and it has low RUNX3/p46 expression, resembling the features of our SS samples.”
BackgroundKießling, M. K., Nicolay, J. P., Schlör, T., Klemke, C., Süss, D., Krammer, P. H., & Gülow, K. (2017) · Oncotarget · doi:10.18632/oncotarget.17669 · Cited by 16
“The CTCL cell lines SeAx [50], Hut78 [51], MyLa [52], and HH [53] were cultured in Roswell Park Memorial Institute (RPMI) medium supplemented with 10% FCS and 1 mM L-Glutamine.”
MethodInfluentialHashizume, H., Hansen, A., Poulsen, L. K., Thomsen, A. R., Takigawa, M., & Thestrup‐Pedersen, K. (2010) · Acta Dermato Venereologica · doi:10.2340/00015555-0927 · Cited by 16
Self-citationAgnholt, J. S., & Kaltoft, K. (2001) · Experimental and Clinical Immunogenetics · doi:10.1159/000049200 · Cited by 16
Self-citationKaltoft, K., Pedersen, C. B., Hansen, B. H., & Thestrup‐Pedersen, K. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(94)00192-8 · Cited by 16
Self-citationThestrup‐Pedersen, K. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13852 · Cited by 15
Self-citationProteome-Based Analysis of Serologically Defined Tumor-Associated Antigens in Cutaneous Lymphoma
Forgber, M., Gellrich, S., Sharav, T., Sterry, W., & Walden, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008376 · Cited by 15
“As protein source, the mycosis fungoides cell line MyLa was used thus focusing the search on shared antigens [42].”
Intrahepatic Xenograft of Cutaneous T-Cell Lymphoma Cell Lines
Andrique, L., Poglio, S., Prochazkova‐Carlotti, M., Kadin, M. E., Giese, A., Idrissi, Y., Beylot-Barry, M., Merlio, J., & Chevret, E. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.03.012 · Cited by 16
Brockdorff, J. L., Woetmann, A., Mustelin, T., Kaltoft, K., Zhang, Q., Wasik, M. A., Röpke, C., & Ødum, N. (2002) · Cytokine · doi:10.1006/cyto.2002.1986 · Cited by 18
Self-citationBrockdorff, J. L., Gu, H., Mustelin, T., Kaltoft, K., Geisler, C., Röpke, C., & Ødum, N. (2001) · Experimental and Clinical Immunogenetics · doi:10.1159/000049187 · Cited by 15
Self-citationBiskup, E., Kamstrup, M. R., Manfé, V., & Gniadecki, R. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12071 · Cited by 14
Cutaneous Lymphocyte Antigen Is a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma
Peru, S., Prochazkova‐Carlotti, M., Cherrier, F., Velazquez, J., Richard, É., Idrissi, Y., Cappellen, D., Martin, L. A., Pham‐Ledard, A., Beylot-Barry, M., et al. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.06.016 · Cited by 13
Linnemann, T., Wiesmüller, K., Gellrich, S., Kaltoft, K., Sterry, W., & Walden, P. (2000) · Annals of Oncology · doi:10.1093/annonc/11.suppl_1.s95 · Cited by 13
Self-citationBourkoula, K., Englert, C., Giaisi, M., Köhler, R., Krammer, P. H., & Li‐Weber, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28379 · Cited by 12
Sumarni, U., Reidel, U., & Eberle, J. (2021) · Cells · doi:10.3390/cells10050987 · Cited by 12
“MyLa derived from a plaque biopsy of a patient with MF [39]; SeAx [40] and HuT-78 [41] derived from PBMCs of patients with S é zary syndrome; HH (ATCC, Manassas, VA, USA; CRL2105) derived from peripheral blood of a patient with aggressive CTCL [42].”
Immunohistochemical expression of IL‐10 in mycosis fungoides
Buhl, L., & SØGAARD, H. (1997) · Experimental Dermatology · doi:10.1111/j.1600-0625.1997.tb00205.x · Cited by 11
Lindahl, L. M., Gluud, M., Emmanuel, T., Thomsen, E., Hu, T., Rittig, A., Celis, P., Stolearenco, V., Krejsgaard, T., Johansen, C., et al. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3574 · Cited by 10
“For in vitro studies the MF-derived cell lines MyLa2059 and MyLa3675 were used (28, 29).”
MethodVallecorsa, P., Venosa, G. M. D., Gola, G. F., Sáenz, D. A., Mamone, L. A., MacRobert, A. J., Ramirez, J. A., & Casas, A. G. (2021) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2021.112244 · Cited by 10
“2 Cell lines The Myla cell line was obtained from a plaque of a patient with MF [33] and the HuT-78 cell line was originated from cells obtained from the blood of a patient with SS [34].”
Background
Metadata
- Authors
- Kaltoft, K., Bisballe, S., Dyrberg, T., Boel, E., Rasmussen, P. B., & Thestrup-Pedersen, K.
- Affiliations
- Aarhus University (DK)
- Novo Nordisk (Denmark) (DK)
- Venue
- In Vitro Cellular & Developmental Biology - Animal
- Published
- 1992-03
- Volume
- 28
- Issue
- 3
- Pages
- 161-167
- ISSN
- 1071-2690 (ISSN-L)
- 0883-8364
- 1543-706X
- OpenAlex
- W2089866605
- Cited by
- 128
- References
- 19
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 8 · 2015: 3 · 2014: 5 · 2013: 4 · 2012: 4
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- In Vitro Cellular & Developmental Biology - Animal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- F. Hoffmann-La Roche
- Topics
- Health Sciences › Medicine › Dermatology › Cutaneous lymphoproliferative disorders research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- mycosis fungoides, cutaneous T-cell lymphoma, cell line establishment, interleukin-2, IL-4, karyotype, chromosomal abnormalities, Sézary syndrome, skin biopsy, malignant T cells
- MeSH terms
- Aged, Aged, 80 and over, Cell Division, Chromosome Aberrations, Culture Media, Humans, Interleukin-2, Karyotyping, Male, Mycosis Fungoides, Receptors, Antigen, T-Cell, Skin Neoplasms, T-Lymphocytes, Tumor Cells, Cultured, Interleukin-4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.